TAS2R50: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD
It’s the GeneMedi’s summary page for Target/Biomarker Introduction of TAS2R50. The page also collects GeneMedi’s different modalities and formats products for TAS2R50 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the TAS2R50 target is also connected to human indications/diseases/conditions/MOA.
Target sublocation: Transmembrane Protein.
TAS2R50 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). See also TAS2R10 (MIM 604791).[supplied by OMIM, Mar 2008]
|
Target ID |
GM-MP1776
|
|
Target Name |
TAS2R50
|
|
Gene ID |
259296
|
|
Gene Official Name |
TAS2R50
|
|
Gene Alias |
T2R50, T2R51, TAS2R51
|
|
Protein Sub-location |
Transmembrane Protein
|
|
Category |
|
Anti-T2R50/ TAS2R50/ T2R51 antibody for FACS & in-vivo assay| GMab
Pre-made anti-TAS2R50 benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TAS2R50 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Warning: Undefined array key "category" in /www/wwwroot/genemedi_com0630/wp-content/plugins/wc-product-table-pro/pro/functions.php on line 2278
